| Serial Number | 87551219 |
| Word Mark | ENABL |
| Filing Date | Tuesday, August 1, 2017 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Tuesday, June 12, 2018 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Research and development services performed for others in the fields of pharmaceutical, medicinal and drug products; namely, research and development services performed for others and research under contract in the fields of antibody libraries, phages, phage display, identifying candidate therapeutic antibodies and manufacture of therapeutic antibodies |
| Pseudo Mark | ENABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, August 4, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Peregrine Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tustin, CA 92780 |
| Event Date | Event Description |
| Tuesday, June 12, 2018 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Tuesday, June 12, 2018 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Friday, November 3, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, November 3, 2017 | NON-FINAL ACTION E-MAILED |
| Friday, November 3, 2017 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 1, 2017 | ASSIGNED TO EXAMINER |
| Friday, August 4, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, August 4, 2017 | NEW APPLICATION ENTERED IN TRAM |